IL7 and acute lymphoblastic leukemia: It was shown that the IL-7/IL-7R axis causes activation of the PI3K/PKB/AKT signaling pathway resulting in downregulation of p27kip1 CDK inhibitors and upregulation of Bcl-2, promoting cell cycle progression and viability of T-ALL cells (173–175).